Nyxoah S.A.

Nyxoah S.A. is a medical technology company that develops and markets innovative solutions for the treatment of obstructive sleep apnea. The company focuses on minimally invasive therapies designed to improve patient outcomes through advanced stimulation technology.

CCI Score

84.75

-0.04% April 18

Latest Event

Nyxoah SA Announces Important Transparency Notification

Nyxoah SA has disclosed significant shareholding changes in compliance with regulatory standards, demonstrating a commitment to transparency and ethical corporate governance which bolsters investor trust.

Take Action

So what can you do? Support Nyxoah by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Argenx

Datavant

Verona Pharma
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

LEADER

Nyxoah S.A. is currently rated as a Leader.

+45 to +100 CCI Score

Companies in this range actively lead the fight against authoritarianism by rejecting oppressive practices and championing democratic values. They implement robust policies, engage in transparent governance, and drive initiatives that set the standard for corporate responsibility.

Latest Events

NOV

15

2025

Nyxoah SA Announces Important Transparency Notification
84.75

Nyxoah SA has disclosed significant shareholding changes in compliance with regulatory standards, demonstrating a commitment to transparency and ethical corporate governance which bolsters investor trust.
+80

Business Practices and Ethical Responsibility

March 26

Nyxoah SA’s proactive disclosure of a significant shift in shareholding emphasizes its adherence to regulatory requirements and transparent corporate practices. This open communication demonstrates ethical business practices that support accountability and reduce potential complicity in opaque governance—an important countermeasure to authoritarian overreach in corporate spheres.

Nyxoah SA Announces Important Transparency Notification - Investors Hangout